Healthcare Finance News September 29, 2022
Susan Morse

The order vacates the drug reimbursement rate for 340B hospitals in the 2022 OPPS Rule.

The Department of Health and Human Services must immediately stop the 30% drug reimbursement cuts to hospitals in the 340B program, a federal judge has ruled.

The order from Judge Rudolph Contreras with the U.S. District Court for the District of Columbia rejects HHS’ plan to wait until January 1, 2023, to restore the full outpatient drug payment rates to 340B hospitals. 

The order vacates the drug reimbursement rate for 340B hospitals in the 2022 Outpatient Prospective Payment System (OPPS) Rule.

Contreras said, “HHS should not be allowed to continue its unlawful 340B reimbursements for the remainder of the year just because it promises to fix...

Today's Sponsors

Zelis
HealthITq
Premier

Today's Sponsors

Upfront Healthcare
pCare

Today's Sponsor

Curation Health

 
Topics: Govt Agencies, Health System / Hospital, HHS, Provider
Mark Cuban in talks with hospitals to solve drug shortages
Research Finds Some Hospitals Are Raising The Cost of Cancer Drugs
Hospitals are hiking cancer drug costs up to 11%, report finds
Opinion: Hospitals and for-profit PBMs are diverting billions in 340B savings from patients in need
Supreme Court sides with low-income hospital groups in decision about drug reimbursements